Pfizer, Johnson & Johnson take steps forward with vaccine trials
Yahoo Finance’s Anjalee Khemlani joins the On the Move panel with the latest on the race for a COVID-19 vaccine. …read more […]
Yahoo Finance’s Anjalee Khemlani joins the On the Move panel with the latest on the race for a COVID-19 vaccine. …read more […]
If you want to know who really controls Precigen, Inc. (NASDAQ:PGEN), then you’ll have to look at the makeup of its… …read more […]
Mittleman Brothers recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Mittleman Global Value Equity Fund – Class P advanced 13.0% net of fees (AUD) in the second quarter of 2020, versus a gain of 6.0% in the MSCI ACW Index. You should check out Mittleman Brothers’ top 5 stock […] …read more […]
(Bloomberg) — U.S. oil exports to China are set to reach a record next month in a sign that Beijing is stepping up purchases to meet its commitments under a landmark trade deal.About 19 tankers have signed provisional bookings to load American crude for China in September, according to shipping fixtures, which are subject to change. If all of them set sail, exports could total 37 million barrels, the most on record for a single month.Under phase one of the agreement between the world’s two biggest economies signed in January, China committed to about $52 billion of U.S. energy purchases …read more […]
Is ‘Fortnite’ done for? Why is Epic at war with Apple and Google? Will you ever be able to download ‘Fortnite’ on your phone again? We cover it all in this week’s Tech Support. …read more […]
* Creates Canada’s Largest Cannabis Retailer with 63 Retail Locations1 and $133 million in Annualized Revenue * Annual Cost and Operational Synergies of Approximately $8 million to $9 million * Strong Balance Sheet with an Estimated $21 million in Combined Cash to Support GrowthCALGARY, AB and TORONTO, Aug. 21, 2020 /CNW/ – High Tide Inc. …read more […]
The U.S. presidential election is only a few months away, and you know what that means. It’s time for the national conventions. This week, Wall Street’s focus has locked in on the race to the White House as the Democratic National Convention kicked off, with the Republican gathering taking place next week.Noting that 2020 may ultimately be remembered as a year of “unconventional conventions,” Oppenheimer’s Chief Investment Strategist John Stoltzfus states that the event will be driven by virtual connectivity. While there are still many unknowns in terms of the market’s trajectory pre- and post-election, the strategist is choosing to …read more […]
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also… …read more […]
Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Emily McCormick break down the earnings reports for Foot Locker and Deere. …read more […]
(Bloomberg) — A multitrillion-dollar beast is prowling Wall Street, making huge market moves that few can see coming — and it’s getting bigger.Known as model portfolio investing, it’s a booming corner of money management in which the likes of BlackRock Inc., Vanguard Group and Charles Schwab Corp. bundle funds into ready-made strategies.It has been around for years, but in an era of fee wars and exchange-traded funds its popularity is exploding. So much cash is now invested that model adjustments are thought to be behind multiple record ETF flows. BlackRock, the world’s largest asset manager, describes them as “crucial” to …read more […]
Covid-19 related campus closures and the shift to remote learning may mark the end of higher learning institutions as we know them.
Chegg CEO Dan Rosensweig says 25% of all universities in the U.S. are likely to close, as cash strapped colleges struggle to adapt to a changing education environment. …read more […]
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few… …read more […]
Pfizer has said repeatedly since June that it was targeting October for its application and the companies started a large late-stage study last month of the candidate vaccine, one of the few globally in later stages of development. On Thursday they reported data from previous early-stage trials of the vaccine, BNT162b2, that showed it induced similar immune responses and had milder side effects than prior data on another candidate. Pfizer stock, down 1% this year, has trailed the stellar rises in value of major pharmaceutical companies this year. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.